journal article
Sep 14, 2020
PTML Modeling for Alzheimer’s Disease: Design and Prediction of Virtual Multi-Target Inhibitors of GSK3B, HDAC1, and HDAC6
Current Topics in Medicinal Chemistry
Vol. 20
No. 19
pp. 1661-1676
·
Bentham Science Publishers Ltd.
Abstract
Background:
Alzheimer’s disease is characterized by a progressive pattern of cognitive and
functional impairment, which ultimately leads to death. Computational approaches have played an important
role in the context of drug discovery for anti-Alzheimer's therapies. However, most of the computational
models reported to date have been focused on only one protein associated with Alzheimer's,
while relying on small datasets of structurally related molecules.
Objective:
We introduce the first model combining perturbation theory and machine learning based on
artificial neural networks (PTML-ANN) for simultaneous prediction and design of inhibitors of three
Alzheimer’s disease-related proteins, namely glycogen synthase kinase 3 beta (GSK3B), histone deacetylase
1 (HDAC1), and histone deacetylase 6 (HDAC6).
Methods:
The PTML-ANN model was obtained from a dataset retrieved from ChEMBL, and it relied on
a classification approach to predict chemicals as active or inactive.
Results:
The PTML-ANN model displayed sensitivity and specificity higher than 85% in both training
and test sets. The physicochemical and structural interpretation of the molecular descriptors in the model
permitted the direct extraction of fragments suggested to favorably contribute to enhancing the multitarget
inhibitory activity. Based on this information, we assembled ten molecules from several fragments
with positive contributions. Seven of these molecules were predicted as triple target inhibitors while the
remaining three were predicted as dual-target inhibitors. The estimated physicochemical properties of
the designed molecules complied with Lipinski’s rule of five and its variants.
Conclusion:
This work opens new horizons toward the design of multi-target inhibitors for anti- Alzheimer's
therapies.
Alzheimer’s disease is characterized by a progressive pattern of cognitive and
functional impairment, which ultimately leads to death. Computational approaches have played an important
role in the context of drug discovery for anti-Alzheimer's therapies. However, most of the computational
models reported to date have been focused on only one protein associated with Alzheimer's,
while relying on small datasets of structurally related molecules.
Objective:
We introduce the first model combining perturbation theory and machine learning based on
artificial neural networks (PTML-ANN) for simultaneous prediction and design of inhibitors of three
Alzheimer’s disease-related proteins, namely glycogen synthase kinase 3 beta (GSK3B), histone deacetylase
1 (HDAC1), and histone deacetylase 6 (HDAC6).
Methods:
The PTML-ANN model was obtained from a dataset retrieved from ChEMBL, and it relied on
a classification approach to predict chemicals as active or inactive.
Results:
The PTML-ANN model displayed sensitivity and specificity higher than 85% in both training
and test sets. The physicochemical and structural interpretation of the molecular descriptors in the model
permitted the direct extraction of fragments suggested to favorably contribute to enhancing the multitarget
inhibitory activity. Based on this information, we assembled ten molecules from several fragments
with positive contributions. Seven of these molecules were predicted as triple target inhibitors while the
remaining three were predicted as dual-target inhibitors. The estimated physicochemical properties of
the designed molecules complied with Lipinski’s rule of five and its variants.
Conclusion:
This work opens new horizons toward the design of multi-target inhibitors for anti- Alzheimer's
therapies.
Topics
No keywords indexed for this article. Browse by subject →
References
78
[1]
Alacreu,M.; Pardo,J.; Azorín,M.; Climent, M.T.; Gasull,V.; Moreno, L. Importance of increasing modifiable risk factors knowledge on alzheimer’s disease among community pharmacists and general practitioners in Spain. Front. Pharmacol. 2019,10,860. http://dx.doi.org/10.3389/fphar.2019.00860 PMID: 31474852
10.3389/fphar.2019.00860
[2]
De Simone,A.; La Pietra,V.; Betari,N.; Petragnani,N.; Conte,M.; Daniele,S.; Pietrobono,D.; Martini,C.; Petralla,S.; Casadei,R.; Davani,L.; Frabetti,F.; Russoma-nno,P.; Nove llino,E.; Montanari,S.; Tumiatti,V.; Ballerini,P.; Sarno,F.; Nebbioso,A.; Altucci,L.; Monti,B.; Andrisano,V.; Milelli, A. Discovery of the first-in-class gsk-3ß/HDAC dual inhibitor as disease-modifying agent to combat Alzheimer’s Disease. ACS Med. Chem. Lett. 2019,10(4),469-474. http://dx.doi.org/10.1021/acsmedchemlett.8b00507 PMID: 30996781
10.1021/acsmedchemlett.8b00507
[3]
Mullard.; A. Pfizer exits neuroscience. Nat. Rev. Drug Discov. 2018,17(2),86. PMID: 29386603
[4]
Oset-Gasque, M.J.; Marco-Contelles, J. Alzheimer’s disease, the “one-molecule, one-target” paradigm, and the multitarget directed ligand approach. ACS Chem. Neurosci. 2018,9 (3),401-403. http://dx.doi.org/10.1021/acschemneuro.8b00069 PMID: 29465220
10.1021/acschemneuro.8b00069
[5]
The GSK3 hypothesis of Alzheimer’s disease
Claudie Hooper, Richard Killick, Simon Lovestone
Journal of Neurochemistry
2008
10.1111/j.1471-4159.2007.05194.x
[6]
The emerging field of epigenetics in neurodegeneration and neuroprotection
Jee-Yeon Hwang, Kelly A. Aromolaran, R. Suzanne Zukin
Nature Reviews Neuroscience
2017
10.1038/nrn.2017.46
[7]
Fischer.; A. Targeting histone-modifications in Alzheimer’s disease. What is the evidence that this is a promising therapeutic avenue? Neuropharmacology. 2014,80,95-102. http://dx.doi.org/10.1016/j.neuropharm.2014.01.038 PMID: 24486385
10.1016/j.neuropharm.2014.01.038
[8]
Bardai, F.H.; Price,V.; Zaayman,M.; Wang,L.; D’Mello, S.R. Histone deacetylase-1 (HDAC1) is a molecular switch between neuronal survival and death, J. Biol. Chem. 2012,287(42),35444-35453. http://dx.doi.org/10.1074/jbc.M112.394544 PMID: 22918830
10.1074/jbc.m112.394544
[9]
Noble,W.; Hanger, D.P.; Miller, C.C.; Lovestone, S. The importance of tau phosphorylation for neurodegenerative diseases. Front. Neurol. 2013,4,83. http://dx.doi.org/10.3389/fneur.2013.00083 PMID: 23847585 [ 10] Fang,J.; Huang,D.; Zhao,W.; Ge,H.; Luo, H.B.; Xu, J. A new protocol for predicting novel GSK-3ß ATP competitive inhibitors, J. Chem. Inf. Model., 2011,51(6),1431-1438. http://dx.doi.org/10.1021/ci2001154 PMID: 21615159
10.3389/fneur.2013.00083
[10]
Paudel,P.; Seong, S.H.; Zhou,Y.; Park, C.H.; Yokozawa,T.; Jung, H.A.; Choi, J.S. Rosmarinic acid derivatives’ inhibition of glycogen synthase kinase-3ß is the pharmacological basis of kangen-karyu in alzheimer’s disease. Molecules. 2018,23(11),23. http://dx.doi.org/10.3390/molecules23112919 PMID: 30413117
10.3390/molecules23112919
[11]
Ruzic,D.; Petkovic,M.; Agbaba,D.; Ganesan,A.; Nikolic, K. Combined ligand and fragment-based drug design of selective histone deacetylase-6 inhibitors. Mol. Inform. 2019,38(5),e1800083. http://dx.doi.org/10.1002/minf.201800083 PMID: 30632697
10.1002/minf.201800083
[12]
Patel,P.; Patel, V.K.; Singh,A.; Jawaid,T.; Kamal,M.; Rajak, H. Identification of hydroxamic acid based selective hdac1 inhibitors: computer aided drug design studies. Curr Comput Aided Drug Des. 2019,15(2),145-166. http://dx.doi.org/10.2174/1573409914666180502113135 PMID: 29732991
10.2174/1573409914666180502113135
[13]
Choubey, S.K.; Jeyaraman, J. A mechanistic approach to explore novel HDAC1 inhibitor using pharmacophore modeling, 3D-QSAR analysis, molecular docking, density functional and molecular dynamics simulation study, J. Mol. Graph. Model. 2016,70,54-69. http://dx.doi.org/10.1016/j.jmgm.2016.09.008 PMID: 27668885
10.1016/j.jmgm.2016.09.008
[14]
Zhu,J.; Wu,Y.; Xu,L.; Jin, J. Theoretical studies on the selectivity mechanisms of glycogen synthase kinase 3beta (gsk3beta) with pyrazine atp-competitive inhibitors by 3d-qsar, molecular docking, molecular dynamics simulation and free energy calculations. Curr Comput Aided Drug Des. 2020,16(1),17–30
[15]
Speck-Planche,A.; Cordeiro, M.N.D.S. Multi-tasking chemoinformatic model for the efficient discovery of potent and safer anti-bladder cancer agents. In: Bladder cancer: Risk factors, emerging treatment strategies and challenges; Haggerty, S. Ed.; Nova Science Publishers, Inc.: New York. 2014,71-93
[16]
Bediaga,H.; Arrasate,S.; González-Díaz, H. PTML combinatorial model of chembl compounds assays for multiple types of cancer. ACS Comb. Sci. 2018,20(11),621-632. http://dx.doi.org/10.1021/acscombsci.8b00090 PMID: 30240186
10.1021/acscombsci.8b00090
[17]
Speck-Planche,A.; Cordeiro, M.N.D.S. Speeding up the virtual design and screening of therapeutic peptides: simultaneous prediction of anticancer activity and cytotoxicity. In: Multi-Scale Approaches in Drug Discovery ; Speck-Planche, A. Ed.; Elsevier: Amsterdam. 2017,127-147. http://dx.doi.org/10.1016/B978-0-08-101129-4.00006-0
10.1016/b978-0-08-101129-4.00006-0
[18]
Kleandrova, V.V.; Ruso, J.M.; Speck-Planche,A.; Dias Soeiro Cordeiro, M.N. Enabling the discovery and virtual screening of potent and safe antimicrobial peptides. simultaneous prediction of antibacterial activity and cytotoxicity. ACS Comb. Sci. 2016,18(8),490-498. http://dx.doi.org/10.1021/acscombsci.6b00063 PMID: 27280735
10.1021/acscombsci.6b00063
[19]
Speck-Planche,A.; Cordeiro, M.N.D.S. Enabling virtual screening of potent and safer antimicrobial agents against noma: mtk-QSBER model for simultaneous prediction of antibacterial activities and ADMET properties. Mini Rev. Med. Chem. 2015,15(3),194-202. http://dx.doi.org/10.2174/138955751503150312120519 PMID: 25769968
10.2174/138955751503150312120519
[20]
Speck-Planche,A.; Cordeiro, M.N.D.S. Computer-aided discovery in antimicrobial research: In silico model for virtual screening of potent and safe anti-pseudomonas agents. Comb. Chem. High Throughput Screen. 2015,18(3),305-314. http://dx.doi.org/10.2174/1386207318666150305144249 PMID: 25747443
10.2174/1386207318666150305144249
[21]
Chemoinformatics for Medicinal Chemistry:
In Silico
Model to Enable the Discovery of Potent and Safer Anti-Cocci Agents
Alejandro Speck-Planche, Maria Natália Dias Soeiro Cordeiro
Future Medicinal Chemistry
2014
10.4155/fmc.14.136
[22]
Speck-Planche,A.; Cordeiro, M.N.D.S. Review of current chemoinformatic tools for modeling important aspects of CYPs-mediated drug metabolism. Integrating metabolism data with other biological profiles to enhance drug discovery. Curr. Drug Metab. 2014,15(4),429-440. http://dx.doi.org/10.2174/1389200215666140605124002 PMID: 24909424
10.2174/1389200215666140605124002
[23]
Speck-Planche,A.; Cordeiro, M.N.D.S. Simultaneous virtual prediction of anti-Escherichia coli activities and ADMET profiles: A chemoinformatic complementary approach for high-throughput screening. ACS Comb. Sci. 2014,16(2),78-84. http://dx.doi.org/10.1021/co400115s PMID: 24383958
10.1021/co400115s
[24]
Herrera-Ibatá, D.M.; Pazos,A.; Orbegozo-Medina, R.A.; Romero-Durán, F.J.; González-Díaz, H. Mapping chemical structure-activity information of HAART-drug cocktails over complex networks of AIDS epidemiology and socioecono mic data of U.S. counties. Biosystems. 2015,132-133,20-34. http://dx.doi.org/10.1016/j.biosystems.2015.04.007 PMID: 25916548
10.1016/j.biosystems.2015.04.007
[25]
Herrera-Ibata, D.M.; Orbegozo-Medina, R.A.; Gonzalez-Diaz, H. Multiscale mapping of AIDS in U.S. c ountries vs anti-HIV drugs activity with complex networks and information indices. Curr. Bioinform. 2015,10,639-657. http://dx.doi.org/10.2174/1574893610666151008012648
10.2174/1574893610666151008012648
[26]
Herrera-Ibata, D.M.; Pazos,A.; Orbegozo-Medina, R.A.; Gonzalez-Diaz, H. Mapping networks of anti-HIV drug cocktails vs. AIDS epidemiology in the US counties. Chemom. Intell. Lab. Syst. 2014,138,161-170. http://dx.doi.org/10.1016/j.chemolab.2014.08.006
10.1016/j.chemolab.2014.08.006
[27]
González-Díaz,H.; Herrera-Ibatá, D.M.; Duardo-Sánchez,A.; Munteanu, C.R.; Orbegozo-Medina, R.A.; Pazos, A. ANN multiscale model of anti-HIV drugs activity vs AIDS prevalence in the US at county level based on information indices of molecular graphs and social networks, J. Chem. Inf. Model. 2014,54(3),744-755. http://dx.doi.org/10.1021/ci400716y PMID: 24521170
10.1021/ci400716y
[28]
Vásquez-Domínguez.; E. Armijos-Jaram illo, V.D.; Tejera,E.; González-Díaz, H. Multioutput Perturbation-Theory Machine Learning (PTML) Model of ChEM BL Data for Antiretroviral Compounds. Mol. Pharm. 2019,16(10),4200-4212. http://dx.doi.org/10.1021/acs.molpharmaceut.9b00538 PMID: 31426639
10.1021/acs.molpharmaceut.9b00538
[29]
Speck-Planche,A.; Kleandrova, V.V.; Cordeiro, M.N.D.S. Chemoinformatics for rational discovery of safe antibacterial drugs: simultaneous predictions of biological activity against streptococci and toxicological profiles in laboratory animals. Bioorg. Med. Chem. 2013,21(10),2727-2732. http://dx.doi.org/10.1016/j.bmc.2013.03.015 PMID: 23582445
10.1016/j.bmc.2013.03.015
[30]
Speck-Planche,A.; Kleandrova, V.V.; Cordeiro, M.N.D.S. New insights toward the discovery of antibacterial agents: multi-tasking QSBER model for the simultaneous prediction of anti-tuberculosis activity and toxicological profiles of drugs. E ur, J. Pharm. Sci. 2013,48(4-5),812-818. http://dx.doi.org/10.1016/j.ejps.2013.01.011 PMID: 23376211
10.1016/j.ejps.2013.01.011
[31]
Speck Planche,A.; Cordeiro, M.N.D.S. In: Chemoinformatics in drug design. Artificial neural networks for simultaneous prediction of anti-enterococci activities and toxicological pro files. Proceedings of the 5th International Joint Conference on Computational Intelligence, NCTA-International Conference on Neural Computation Theory and Applications, Vilamoura, Algarve, Portugal, September 20-22,2013; Institute for Systems and Technologies of Information, Control and Communication (INSTICC): Vilamoura, Algarve, Portugal. 2013, p. 458-465
[32]
Nocedo-Mena,D.; Cornelio,C.; Camacho-Corona, M.D.R.; Garza-González,E.; Waksman-de Torres,N.; Arrasate,S.; Sotomayor,N.; Lete,E.; González-Díaz, H. Modeling antibacterial activity with machine learning and fusion of chemical structure information with microorganism metabolic networks, J. Chem. Inf. Model. 2019,59(3),1109-1120. http://dx.doi.org/10.1021/acs.jcim.9b00034 PMID: 30802402
10.1021/acs.jcim.9b00034
[33]
Concu,R.; Kleandrova, V.V.; Speck-Planche,A.; Cordeiro, M.N.D.S. Probing the toxicity of nanoparticles: a unified in silico machine learning model based on perturbation theory. Nanotoxicology. 2017,11(7),891-906. http://dx.doi.org/10.1080/17435390.2017.1379567 PMID: 28937298
10.1080/17435390.2017.1379567
[34]
Speck-Planche,A.; Kleandrova, V.V.; Luan,F.; Cordeiro, M.N.D.S. Computational modeling in nanomedicine: prediction of multiple antibacterial profiles of nanoparticles using a quantitative structure-activity relationship perturbation model. Nanomedicine (Lond.),2015,10(2),193-204. http://dx.doi.org/10.2217/nnm.14.96 PMID: 25600965
[35]
Computer-aided nanotoxicology: assessing cytotoxicity of nanoparticles under diverse experimental conditions by using a novel QSTR-perturbation approach
Feng Luan, Valeria V. Kleandrova, Humberto Gonzalez-Diaz et al.
Nanoscale
2014
10.1039/c4nr01285b
[36]
Kleandrova, V.V.; Luan,F.; González-Díaz,H.; Ruso, J.M.; Speck-Planche,A.; Cordeiro, M.N.D.S. Computational tool for risk assessment of nanomaterials: novel QSTR-perturbation model for simultaneous prediction of ecotoxicity and cytotoxicity of uncoated and coated nanoparticles under multiple experimental conditions. Environ. Sci. Technol. 2014,48(24),14686-14694. http://dx.doi.org/10.1021/es503861x PMID: 25384130
10.1021/es503861x
[37]
Kleandrova, V.V.; Luan,F.; González-Díaz,H.; Ruso, J.M.; Melo,A.; Speck-Planche,A.; Cordeiro, M.N.D.S. Computational ecotoxicology: simultaneous prediction of ecotoxic effects of nanoparticles under different experimental conditions. Environ. Int. 2014,73,288-294. http://dx.doi.org/10.1016/j.envint.2014.08.009 PMID: 25173945
10.1016/j.envint.2014.08.009
[38]
Martínez-Arzate, S.G.; Tenorio-Borroto,E.; Barbabosa Pliego,A.; Díaz-Albiter, H.M.; Vázquez-Chagoyán, J.C.; González-Díaz, H. PTML Model for proteome mining of B-cell epitopes and theoretical-experimental study of bm86 protein sequences from Colima, Mexico, J. Proteome Res. 2017,16( 11),4093-4103. http://dx.doi.org/10.1021/acs.jproteome.7b00477 PMID: 28922600
10.1021/acs.jproteome.7b00477
[39]
Tenorio-Borroto,E.; Castañedo,N.; García-Mera,X.; Rivadeneira,K.; Vázquez Chagoyán, J.C.; Barbabosa Pliego,A.; Munteanu, C.R.; González-Díaz, H. Perturbation theory machine learning modeling of immunotoxicity for drugs targeting inflammatory cytokines and study of the antimicrobial g1 using cytometric bead arrays. Chem. Res. Toxicol. 2019,32(9),1811-1823. http://dx.doi.org/10.1021/acs.chemrestox.9b00154 PMID: 31327231
10.1021/acs.chemrestox.9b00154
[40]
Tenorio-Borroto,E.; Ramirez, F.R.; Speck-Planche,A.; Cordeiro, M.N.D.S.; Luan,F.; Gonzalez-Diaz, H. QSPR and flow cytometry analysis (QSPR-FCA): review and new findings on parallel study of multiple interactions of chemical compo unds with immune cellular and molecular targets. Curr. Drug Metab. 2014,15(4),414-428. http://dx.doi.org/10.2174/1389200215666140908101152 PMID: 25204826
10.2174/1389200215666140908101152
[41]
Tenorio-Borroto,E.; Peñuelas-Rivas, C.G.; Vásquez-Chagoyán, J.C.; Castañedo,N.; Prado-Prado, F.J.; García-Mera,X.; González-Díaz, H. Model for high-throughput screening of drug immunotoxicity--study of the anti-microbial G1 over peritoneal macrophages using flow cytometry. Eur, J. Med. Chem. 2014,72,206-220. http://dx.doi.org/10.1016/j.ejmech.2013.08.035 PMID: 24445280
10.1016/j.ejmech.2013.08.035
[42]
González-Díaz,H.; Pérez-Montoto, L.G.; Ubeira, F.M. Model for vaccine design by prediction of B-epitopes of IEDB given perturbations in peptide sequence, in vivo process, experimental techniques, and source or host organisms, J. Immunol. Res. 2014,2014,768515. http://dx.doi.org/10.1155/2014/768515 PMID: 24741624
10.1155/2014/768515
[43]
Tenorio-Borroto,E.; García-Mera,X.; Peñuelas-Rivas, C.G.; Vásquez-Chagoyán, J.C.; Prado-Prado, F.J.; Castañedo,N.; González-Díaz, H. Entropy model for mu ltiplex drug-target interaction endpoints of drug immunotoxicity. Curr. Top. Med. Chem. 2013,13(14),1636-1649. http://dx.doi.org/10.2174/15680266113139990114 PMID: 23889053
10.2174/15680266113139990114
[44]
Romero-Durán, F.J.; Alonso,N.; Yañez,M.; Caamaño,O.; García-Mera,X.; González-Díaz, H. Brain-inspired cheminformatics of drug-target brain interactome, synthesis, and assay of TVP1022 derivatives. Neuropharmacology. 2016,103,270-278. http://dx.doi.org/10.1016/j.neuropharm.2015.12.019 PMID: 26721628
10.1016/j.neuropharm.2015.12.019
[45]
Romero Durán, F.J.; Alonso,N.; Caamaño,O.; García-Mera,X.; Yañez,M.; Prado-Prado, F.J.; González-Díaz, H. Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric 1,2-rasagiline carbamates. Int, J. Mol. Sci. 2014,15(9),17035-17064. http://dx.doi.org/10.3390/ijms 150917035 PMID: 25255029
10.3390/ijms 150917035
[46]
Luan,F.; Cordeiro, M.N.D.S.; Alonso,N.; García-Mera,X.; C aamaño,O.; Romero-Duran, F.J.; Yañez,M.; González-Díaz, H. TOPS-MODE model of multiplexing neuroprotective effects of drugs and experimental-theoretic study of new 1,3-rasagiline derivatives potentially useful in neurodegenerative diseases. Bioorg. Med. Chem. 2013,21(7),1870-1879. http://dx.doi.org/10.1016/j.bmc.2013.01.035 PMID: 23415089
10.1016/j.bmc.2013.01.035
[47]
Ferreira da Costa,J.; Silva,D.; Caamaño,O.; Brea, J.M.; Loza, M.I.; Munteanu, C.R.; Pazos,A.; García-Mera,X.; González-Díaz, H. Perturbation theory/machine learning model of chembl data for dopamine targets: docking, synthesis, and assay of new l-prolyl-l-leucyl-glycinamide peptidomimetics. ACS Chem. Neurosci. 2018,9(11),2572-2587. http://dx.doi.org/10.1021/acschemneuro.8b00083 PMID: 29791132
10.1021/acschemneuro.8b00083
[48]
Speck-Planche,A.; Kleandrova, V.V.; Luan,F.; Cordeiro, M.N.D.S. Multi-target inhibitors for proteins associated with Alzheimer: In silico discovery using fragment-based descriptors. Curr. Alzheimer Res. 2013,10(2),117-124. http://dx.doi.org/10.2174/1567205011310020001 PMID: 22515494
10.2174/1567205011310020001
[49]
Alonso,N.; Caamaño,O.; Romero-Duran, F.J.; Luan,F.; D S Cordeiro, M.N.; Yañez,M.; González-Díaz,H.; García-Mera, X. Model for high-throughput screening of multitarget drugs in chemical neurosciences: synthesis, assay, and theoretic study of rasagiline carbamates. ACS Chem. Neurosci. 2013,4(10),1393-1403. http://dx.doi.org/10.1021/cn400111n PMID: 23855599
10.1021/cn400111n
[50]
ChEMBL: a large-scale bioactivity database for drug discovery
A. Gaulton, L. J. Bellis, A. P. Bento et al.
Nucleic Acids Research
2012
10.1093/nar/gkr777
Showing 50 of 78 references
Metrics
34
Citations
78
References
Details
- Published
- Sep 14, 2020
- Vol/Issue
- 20(19)
- Pages
- 1661-1676
Authors
Cite This Article
Valeria V. Kleandrova, Alejandro Speck-Planche (2020). PTML Modeling for Alzheimer’s Disease: Design and Prediction of Virtual Multi-Target Inhibitors of GSK3B, HDAC1, and HDAC6. Current Topics in Medicinal Chemistry, 20(19), 1661-1676. https://doi.org/10.2174/1568026620666200607190951
Related
You May Also Like
Sulfur Containing Scaffolds in Drugs: Synthesis and Application in Medicinal Chemistry
Minghao Feng, Bingqing Tang · 2016
1,840 citations
Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
Evanthia Lionta, George Spyrou · 2014
914 citations
Antimicrobial Peptide Structure and Mechanism of Action: A Focus on the Role of Membrane Structure
Tzong-Hsien Lee, Kristopher N. Hall · 2015
398 citations
Advancements in Docking and Molecular Dynamics Simulations Towards Ligand-receptor Interactions and Structure-function Relationships
Ahmad Abu Turab Naqvi, Taj Mohammad · 2018
397 citations
Thiazole: A Review on Chemistry, Synthesis and Therapeutic Importance of its Derivatives
Mahesh T. Chhabria, Shivani Patel · 2016
330 citations